Abstract
SCD research in Europe is limited by the relatively small, variable, and widely dispersed patient cohorts. In addition, the lack of harmonization among the repositories hampers world-wide collaborations. Artificial Intelligence (AI) can aid in analyzing large quantities of data, but only if it is collected and organized in a standardized way. To overcome some of the presented issues, GenoMed4All6 is a European initiative to provide personalized solutions for hematological diseases’ control and prevention by exploiting the power of AI.